Tool for the Detection of Oncogeriatric Fragility in Patients Aged ≥75 Years Undergoing Oncological Treatment.(D-FOG)

Study Overview
=================
Brief Summary
-----------------
Many cancers are diagnosed after 75 years. Treatment in chemotherapy begins without evidence of geriatric risk factors. A new tool for screening for geriatric fragilities is used, a self-administered questionnaire carried out by the patient before each chemotherapy cure. The objective is to secure the quality of patient care and to detect the appearance and / or aggravation of geriatric fragilities.

Detailed Description
-----------------
Evaluation of the feasibility of a new geriatric fragility screening tool (D-FOG) in patients aged ≥ 75 years during oncological treatment: Number of D-FOGs filled in: comparison with the number of patients included in the study and the number of visits of each patient. Regularity of the D-FOG self-questionnaire by the patient: comparison with the number of visits of the patient for a chemotherapy cure (HDJ or HDS). Number of criteria entered by D-FOG: comparison with the total number of criteria to be filled in Criterion analysis of D-FOG

Official Title
-----------------
Tool for the Detection of Oncogeriatric Fragility in Patients Aged ≥75 Years Undergoing Oncological Treatment. Feasibility and Acceptability Study.

Conditions
-----------------
Cancer, 75 Years Old and More, Chemotherapy

Intervention / Treatment
-----------------
* Other: Self-questionnaire


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Patients aged 75 years and over Carriers of diagnosed cancer (excluding hematology) Whatever the location, uniqueness or multiple, duration of development and treatment status (adjuvant, neoadjuvant, locally advanced or metastatic) Seen in nursing consultant Beginning an oncological treatment Supported for oncology day hospital (HDJ) or weekly (HDS) chemotherapy Patient not opposed to participate in the study Exclusion Criteria: Patients under 75 years of age Having not had an IDE ad consultation During oncological treatment Receiving Oral Therapy or hormone therapy alone Treated by radiotherapy alone or surgery alone Not attending a day or week oncology hospital Refusal to participate in research

Ages Eligible for Study
-----------------
Minimum Age: 75 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Group D-FOG<br>Filling of a self-questionnaire before each chemotherapy cure | Other: Self-questionnaire<br>* Filling of a self-questionnaire before each chemotherapy cure<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Evaluation of the feasibility of a new geriatric fragility screening tool (D-FOG) in patients aged ≥ 75 years during oncological treatment. | Feasibility of D-FOG for patients : number of D-FOGs filled in, regularity of the D-FOG self-questionnaire by the patient, number of criteria entered by D-FOG, criterion analysis of D-FOG | 3 months | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
cancer, chemotherapy